Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help ...
Co announces a multi-year contract extension with Laboratory Corporation of America Holdings (LabCorp) (LH) for Cytyc's ThinPrep Imaging System and the ThinPrep Pap Test. Over the term of the contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback